文献速递慢性肾脏病急性肾损伤

儿童异基因造血干细胞移植后十年慢性肾脏病研究

Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation.
PubMed 文献 · Kidney Int · 2021-06-05

该单中心队列研究纳入2002-2012年接受HSCT的216例儿童幸存者,评估移植后十年eGFR动态、蛋白尿和高血压。eGFR中位数从移植前148降至十年后116 ml/min/1.73 m2,17%发生CKD。严重迁延性AKI(eGFR<60且持续≥28天)是CKD主要危险因素(HR 9.5,95%CI 3.4-27),血液系统恶性肿瘤为独立危险因素。

要点

  • 儿童HSCT后十年内17%发生CKD,需长期监测eGFR、尿蛋白和血压。
  • 严重迁延性AKI(eGFR<60持续≥28天)是CKD主要危险因素,HR 9.5。
  • 血液系统恶性肿瘤作为HSCT指征是CKD独立危险因素。

核心结论

  • 相当比例儿童HSCT受者在十年内发生CKD,应结构化长期监测以及时发现早期CKD。

研究设计与样本

  • 单中心队列研究,纳入2002-2012年接受HSCT的216例儿童幸存者,评估移植后十年eGFR动态、蛋白尿和高血压。

主要发现

  • eGFR中位数从移植前148降至移植后十年116 ml/min/1.73 m2。
  • CKD(KDIGO G2或A2及以上;eGFR<90 ml/min/1.73 m2和/或白蛋白尿)发生于17%的患者。
  • 多变量分析中,严重迁延性2期及以上AKI(eGFR<60 ml/min/1.73 m2且持续28天及以上)是CKD主要危险因素(HR 9.5,95%CI 3.4-27)。
  • 2期及以上AKI但eGFR≥60 ml/min/1.73 m2,或KDIGO 2期及以上AKI且eGFR<60 ml/min/1.73 m2但在28天内恢复,均与CKD无关。
  • 血液系统恶性肿瘤作为HSCT指征是CKD独立危险因素。

关键数值与推荐

  • CKD定义采用KDIGO G2或A2及以上:eGFR<90 ml/min/1.73 m2和/或白蛋白尿。
  • 严重迁延性AKI定义为2期及以上AKI伴eGFR<60 ml/min/1.73 m2且持续时间≥28天。
  • CKD患者中三分之一同时符合两项标准,三分之一仅有eGFR降低,三分之一仅有白蛋白尿。
  • CKD患者高血压发生率为27%,无CKD患者为4.4%。
  • 71例有β2-微球蛋白尿数据的亚组中,7%存在肾小管性蛋白尿。

临床怎么用

  • 儿童HSCT后应长期结构化监测eGFR、尿蛋白和血压,以识别可从肾保护干预中获益的早期CKD患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease (CKD) is an important sequela of hematopoietic stem cell transplantation (HSCT), but data regarding CKD after pediatric HSCT are limited. In this single center cohort study, we evaluated the estimated glomerular filtration rate (eGFR) dynamics, proteinuria and hypertension in the first decade after HSCT and assessed risk factors for CKD in 216 pediatric HSCT survivors, transplanted 2002-2012. The eGFR decreased from a median of 148 to 116 ml/min/1.73 m2 between pre-HSCT to ten years post-HSCT. CKD (KDIGO stages G2 or A2 or more; eGFR under 90 ml/min/1.73m2 and/or albuminuria) occurred in 17% of patients. In multivariate analysis, severe prolonged stage 2 or more acute kidney injury (AKI), with an eGFR under 60ml/min/1.73m2 and duration of 28 days or more, was the main risk factor for CKD (hazard ratio 9.5, 95% confidence interval 3.4-27). Stage 2 or more AKI with an eGFR of 60ml/min/1.73m2 or more and KDIGO stage 2 or more AKI with eGFR under 60ml/min/1.73m2 but recovery within 28 days were not associated with CKD. Furthermore, hematological malignancy as HSCT indication was an independent risk factor for CKD. One third of patients had both CKD criteria, one third had isolated eGFR reduction and one third only had albuminuria. Hypertension occurred in 27% of patients with CKD compared to 4.4% of patients without. Tubular proteinuria was present in 7% of a subgroup of 71 patients with available β2-microglobulinuria. Thus, a significant proportion of pediatric HSCT recipients developed CKD within ten years. Our data stress the importance of structural long-term monitoring of eGFR, urine and blood pressure after HSCT to identify patients with incipient CKD who can benefit from nephroprotective interventions.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Lugthart G, Jordans CCE, de Pagter APJ, et al. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation. Kidney Int. 2021. PMID: 34102218. doi:10.1016/j.kint.2021.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。